Recombinant multi-species Thioredoxin/TXN protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Thioredoxin/TXN protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene acts as a homodimer and is involved in many redox reactions. The encoded protein is active in the reversible S-nitrosylation of cysteines in certain proteins, which is part of the response to intracellular nitric oxide. This protein is found in the cytoplasm. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]
The Alternative Names of target: Thioredoxin, TXN,Thioredoxin,Trx,ATL-derived factor (ADF), Surface-associated sulphydryl protein (SASP),TRX,TRDX,TRX1,TXN1,Trx80
Go
to Thioredoxin/TXN products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T85616-Ab-1/ GM-Tg-hg-T85616-Ab-2 | Human Thioredoxin/TXN protein | Human |
GM-Tg-rg-T85616-Ab-1/ GM-Tg-rg-T85616-Ab-2 | Rat Thioredoxin/TXN protein | Rat |
GM-Tg-mg-T85616-Ab-1/ GM-Tg-mg-T85616-Ab-2 | Mouse Thioredoxin/TXN protein | Mouse |
GM-Tg-cynog-T85616-Ab-1/ GM-Tg-cynog-T85616-Ab-2 | Cynomolgus/Rhesus macaque Thioredoxin/TXN monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T85616-Ab-1/ GM-Tg-felg-T85616-Ab-2 | Feline Thioredoxin/TXN protein | Feline |
GM-Tg-cang-T85616-Ab-1/ GM-Tg-cang-T85616-Ab-2 | Canine Thioredoxin/TXN protein | Canine |
GM-Tg-bovg-T85616-Ab-1/ GM-Tg-bovg-T85616-Ab-2 | Bovine Thioredoxin/TXN protein | Bovine |
GM-Tg-equg-T85616-Ab-1/ GM-Tg-equg-T85616-Ab-2 | Equine Thioredoxin/TXN protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. |
GM-Tg-hg-T85616-Ab-1/ GM-Tg-hg-T85616-Ab-2;
GM-Tg-rg-T85616-Ab-1/ GM-Tg-rg-T85616-Ab-2;
GM-Tg-mg-T85616-Ab-1/ GM-Tg-mg-T85616-Ab-2; GM-Tg-cynog-T85616-Ab-1/ GM-Tg-cynog-T85616-Ab-2; GM-Tg-felg-T85616-Ab-1/ GM-Tg-felg-T85616-Ab-2; GM-Tg-cang-T85616-Ab-1/ GM-Tg-cang-T85616-Ab-2; GM-Tg-bovg-T85616-Ab-1/ GM-Tg-bovg-T85616-Ab-2; GM-Tg-equg-T85616-Ab-1/ GM-Tg-equg-T85616-Ab-2 |
Products Name | Thioredoxin/TXN protein |
Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
Target Name | Thioredoxin/TXN |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Isotypes | Recombinant protein |
Expression platform | Mammalian cell |
Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
Tag | His |
Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Thioredoxin/TXN protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab
GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.